High adiponectin level in late postmenopausal women with normal renal function

Clinica Chimica Acta

Volumn 430, Issue , 2014, Pages 104-108

  Matsui, Sumika ^a   Yasui, Toshiyuki ^a   Keyama, Kaoru ^a   Tani, Anna ^a   Kato, Takeshi ^a   Uemura, Hirokazu ^a   Kuwahara, Akira ^a   Matsuzaki, Toshiya ^a   Irahara, Minoru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Adiponectin; Insulin resistance; Late postmenopause; Lipid profiles; Renal function

Indexed keywords

ADIPONECTIN; CREATININE; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NITROGEN; TESTOSTERONE; TRIACYLGLYCEROL; UREA;

ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID METABOLISM; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; BLOOD; KIDNEY; KIDNEY FUNCTION TEST; MIDDLE AGED; PHYSIOLOGY;

ADIPONECTIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MIDDLE AGED; POSTMENOPAUSE;

EID: 84893117904     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.12.037     Document Type: Article

References (26)

1. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996, 221(2):286-289.
2. Díez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148(3):293-300.
3. Ryo M., Nakamura T., Kihara S., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68(11):975-981.
4. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002, 13(1):134-141.
5. Matsuura F., Oku H., Koseki M., et al. Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochem Biophys Res Commun 2007, 358(4):1091-1095.
6. Gavrila A., Chan J.L., Yiannakouris N., et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003, 88(10):4823-4831.
7. Leung K.C., Xu A., Craig M.E., Martin A., Lam K.S., O'Sullivan A.J. Adiponectin isoform distribution in women-relationship to female sex steroids and insulin sensitivity. Metabolism 2009, 58(2):239-245.
8. Tamakoshi K., Yatsuya H., Wada K., et al. The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clin Endocrinol (Oxf) 2007, 66(1):65-71.
9. Lee C.G., Carr M.C., Murdoch S.J., et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009, 94(4):1104-1110.
10. Matsui S., Yasui T., Tani A., et al. Association of circulating adiponectin with testosterone in women during the menopausal transition. Maturitas 2012, 73(3):255-260.
11. Matsui S., Yasui T., Tani A., et al. Associations of estrogen and testosterone with insulin resistance in pre- and postmenopausal women with and without hormone therapy. Int J Endocrinol Metab 2013, 11(2):65-70.
12. Huang J.W., Yen C.J., Chiang H.W., Hung K.Y., Tsai T.J., Wu K.D. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004, 43(6):1047-1055.
13. Guebre-Egziabher F., Bernhard J., Funahashi T., Hadj-Aissa A., Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005, 20(1):129-134.
14. Isobe T., Saitoh S., Takagi S., et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol 2005, 153(1):91-98.
15. Kawamoto R., Tabara Y., Kohara K., et al. Serum high molecular weight adiponectin is associated with mild renal dysfunction in Japanese adults. J Atheroscler Thromb 2010, 17(11):1141-1148.
16. Doumatey A.P., Zhou J., Huang H., et al. Circulating adiponectin is associated with renal function independent of age and serum lipids in west Africans. Int J Nephrol 2012, 730920.
17. Soules M.R., Sherman S., Parrott E., et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001, 4(4):267-272.
18. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005, 67(6):2089-2100.
19. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257(1):79-83.
20. Vermeulen A., Verdonck L., Kaufman J.M. A criteria evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84:3666-3672.
21. Imai E., Horio M., Watanabe T., et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009, 13(6):621-630.
22. Storgaard H., Poulsen P., Ling C., Groop L., Vaag A.A. Relationships of plasma adiponectin level and adiponectin receptors 1 and 2 gene expression to insulin sensitivity and glucose and fat metabolism in monozygotic and dizygotic twins. J Clin Endocrinol Metab 2007, 92(7):2835-2839.
23. Waki H., Yamauchi T., Kamon J., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003, 278(41):40352-40363.
24. Hara K., Horikoshi M., Yamauchi T., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29(6):1357-1362.
25. Lara-Castro C., Luo N., Wallace P., Klein R.L., Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55(1):249-259.
26. Furuhashi M., Ura N., Higashiura K., et al. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42(1):76-81.